Elanco Animal Health EBITDA 2016-2026 | ELAN
Elanco Animal Health annual and quarterly EBITDA history from 2016 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Elanco Animal Health EBITDA for the quarter ending June 30, 2026 was $280M, a 10.67% increase year-over-year.
- Elanco Animal Health EBITDA for the twelve months ending June 30, 2026 was $774M, a 7.75% decline year-over-year.
- Elanco Animal Health 2025 annual EBITDA was $0.695B, a 8.91% decline from 2024.
- Elanco Animal Health 2024 annual EBITDA was $0.763B, a 612.08% decline from 2023.
- Elanco Animal Health 2023 annual EBITDA was $-0.149B, a 116.87% decline from 2022.
|
Elanco Animal Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $695 |
| 2024 | $763 |
| 2023 | $-149 |
| 2022 | $883 |
| 2021 | $386 |
| 2020 | $-188 |
| 2019 | $499 |
| 2018 | $481 |
| 2017 | $86 |
| 2016 | $229 |
| 2015 | $-21 |
|
Elanco Animal Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-06-30 | $280 |
| 2026-03-31 | $325 |
| 2025-12-31 | $-9 |
| 2025-09-30 | $178 |
| 2025-06-30 | $253 |
| 2025-03-31 | $273 |
| 2024-12-31 | $165 |
| 2024-09-30 | $148 |
| 2024-06-30 | $197 |
| 2024-03-31 | $253 |
| 2023-12-31 | $145 |
| 2023-09-30 | $-843 |
| 2023-06-30 | $195 |
| 2023-03-31 | $354 |
| 2022-12-31 | $162 |
| 2022-09-30 | $191 |
| 2022-06-30 | $218 |
| 2022-03-31 | $312 |
| 2021-12-31 | $101 |
| 2021-09-30 | $111 |
| 2021-06-30 | $-9 |
| 2021-03-31 | $183 |
| 2020-12-31 | $-56 |
| 2020-09-30 | $-143 |
| 2020-06-30 | $-20 |
| 2020-03-31 | $31 |
| 2019-12-31 | $104 |
| 2019-09-30 | $100 |
| 2019-06-30 | $152 |
| 2019-03-31 | $143 |
| 2018-12-31 | $118 |
| 2018-09-30 | $165 |
| 2018-06-30 | $44 |
| 2018-03-31 | $154 |
| 2017-09-30 | $-11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.491B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |